ABSTRACT
INTRODUCTION
odon 72 belongs to the exon 4 and has either the sequence CCC, which encodes proline, or CGC, which encodes arginine. Giving three allelic variants Pro/Pro, Arg/Arg and the heterozygous Pro/Arg [1] . This amino acid change results in structural changes with distinct biochemical and functional properties of the p53 protein with difference in its ability to signal apoptosis following ultra violet induced damage and hence influencing the cancer risk.
[2] p53 codon 72 polymorphisms was reported to be affected with geographic distribution and the ethnic factors change. The frequency of p53-72 Arginine variant also reported to be increased with geographic distance from the equator and fair skin populations have a higher frequency of this allele.
[3] The role of p53 codon 72 polymorphisms in non-melanocytic skin carcinomas (NMSCs) is still not clear. Dokianakis et al [4] suggested that p53 Arg homozygosity could represent a potential risk factor for high risk HPV related skin cancer in immunocompetent patients. Whereas McGregor et al [1] found that the arginine form of p53 is a risk factor to sun burn and NMSC in immunosuppressed individuals only. Furthermore, De Oliveira et al [5] indicated from a study on Brazilian Epidermodysplasia Verruciforms (EV) patients that all malignant form of EV patients were arginine homozygous in contrast with the benign form. However, Bendesky, et al [6] results revealed no significant association between p53 genotype and basal cell carcinoma( BCC), squamous cell carcinoma (SCC) or both combined and showed no differences regarding the basal level of DNA damage or DNA repair capacity among the different allelic forms. A similar finding was reported by O`conner, et al [7] which concluded there was no correlation between the presence of HPV, the p53 codon 72 arginine polymorphism, and the development of skin cancer. On the other hand Pezeshki, et al [8] were studied the association between BCC development and the p53 codon 72 polymorphism in Iranian population. No significant changes were reported from this study. However, there was an apparent increase in the Arg/Arg genotype among sun exposed patients compared to controls which suggested that Arg allele genotype might affect the risk of ultraviolet induced basal cell carcinoma. There are few conflicting studies on the role of Human papilloma virus in BCC ranging from serological to molecular studies. Most of these studies conclude a negative association. [9, 10] Therefore, this study was conducted to evaluate the association of p53 codon 72 polymorphism and HPV 5,8 E6 oncoprotein expression in basal cell carcinoma of the skin. Reverse Transcriptases and HotStarTaq DNA Polymerase) 2 ul was used with 1.5 ul of each primer, 2ul dNTP Mix, 10 ul of 5x QIAGEN One-step RT-PCR Buffer, 10 ul RNA template and 20 ul RNAase free water to complete the volume to 50 ul. The Thermal cycler conditions include:30 min reverse transcription at 50 Cº followed by initial PCR activation step for 15 min at 95Cº, then 25 cycles of 0.5 min denaturation step at 95Cº, 0.5 min annealing step at 59Cºand 0.5 min extension step at 72Cº and finally 10 min extension step at 72Cº. Similarly, RT-PCR component was used for detection of HPV 8 E6 oncoprotein (HPV 8 E6 FW 5#-CCGCAACGTTTGAATTTAATG-3#, HPV 8 E6 Rev 5#-ATTGAACGTCCTGTAGCTAATTCA-3# with change of annealing condition in the thermal cycling program to (57Cº). Agarose gel (2.5%) was used to analyse the RT -PCR product. The estimated product size for the internal control (beta globin) is 270bp and for HPV 5E6 transcript is 77 bp and 55 bp for HPV 8 E6 as calculated from PavE papilloma virus episteme , at papilloma virus specific blast (the amplicon size equals the lower sequence number of the forward strand from the lower sequence number of the reverse strand). Statistical analyses, were performed using (SPSS) for Windows (version 20). Pearson Chisquare was used to determine any significant difference in the distribution of demographic characters and genotypes frequency between cases and controls.
MATERIALS AND METHODS

RESULTS
The age of the 29 patients ranged from (40-85 years) with a mean 59.6 while the age of the 31 controls ranged from (36-85 years) with a mean of (55.8). The male sex was predominate in both groups presenting 58.6% for cases and 54.8% for controls.
The Polymerase Chain Reaction -Restriction Fragment Length polymorphism (PCR-RFLP) products were analysed on 2.5% ethidium bromide stained agarose gel as shown in Figure  1 . The frequency of Arg/Arg, Pro/Pro or Arg /Pro were 10.3%, 24.1% and 65.5% respectively among patients group and 6.5%, 58.1% and 35.5% among the control group, ( 
Reverse transcription PCR for HPV 5,8 E6 oncoproteins
Amplified products were loaded to 2.5% agarose gel for detection of E6 oncoprotein of HPV 5 (77 bp) and HPV 8 (55bp) which were not visualized in all tested samples although the internal control (beta actin) bands was clear at 270 bp position and amplified in most of the samples (Figure 2 ).
DISCUSSION
The main finding of the current study is that patients carrying the p53 codon 72 Arg/pro genotype have more risk of getting BCC as compared with Pro/Pro variant (OR = 4.44, 95% CI = 1.4118 to 13.9733) and according to the dominant model (Arg/Arg + Arg/Pro versus Pro/Pro) the association is significant (P < 0.05) with odds ratio (OR) = 4.3, 95% confidence interval (CI): 1.4340-13.2059 and the P-value 0.0077. The dominance of the heterozygous variant (Arg/Pro) in the BCC cases group in our population may reflect functional changes as stated by Levine et al. [11] However, the change in this amino acid may results in structural changes with distinct biochemical and functional properties of the p53 proteins with differences in the ability to signal apoptosis, hence influencing the cancer risk. [1, 8] The finding of negative HPV 5,8 E6 RNA expression in all studied BCC biopsies may reflect the negative association of these viruses and BCC aetiology. Due to high prevalence of beta HPV in the skin of healthy individuals, we tried to analysed the E6 oncoprotein expression of the most commonly studied types HPV5 and 8 other than studying the HPV DNA only. In a study by Dang et al [12] one case of BCC was included to study the HPV 5,8 E6/E7 RNA expression in tumor biopsies of NMSC using real time RT PCR. The study of Dang et al [12] revealed an increase in the transcriptional activity in actinic carcinoma and squamous cell carcinoma biopsy only. The negative expression of HPV 5,8 E6 oncoprotein in BCC samples may further coincides with the negative relationship of beta HPV and BCC obtained by other studies. [10, 13, 14] A study conducted by
Mokhtari, et al [13] which were using immunohistochemistry, no HPV DNA was detected in all BCC biopsies. However, lannacome et al [10] carried out the first and largest case control study that focused on BCC rather than SCC or NMSC using molecular and serological methods and the researchers were suggested that HPV is not involved in BCC carcinogensis. In addition Nahidi etal [4] in an investigation on Iranian population concluded that HPV infection which was assessed by PCR using GP+5/GP+6 primers for L1 region of HPV DNA had no significant role in BCC pathogenesis. It has been reported that heterozygous variant Arg/Pro decreases the susceptibility to HPV E6 oncoprotein degradation which is increased in homozygous of Arg allele. [15] On the other hand, studies demonstrated that the Arg form is a potent inducer of apoptosis than the proline form, in contrast p53 proline form is a strong inducer of transcription than p53 Arg form 2 which may clarify the reason for the negative expression of the viral oncoprotein in this study due to the dominance of hetrozygosity of p53 genotypes in our population where individuals with Arg/Arg homozygous variant are more susceptible to HPV associated carcinogenesis, thus Arg/Pro heterozygous or Pro/Pro homozygous variant of p53 codon 72 decreases this susceptibility. [16, 17] Several studies have shown inconsistent and conflicting results on the genetic susceptibility role of the p53 codon 72 polymorphism in BCC that have been attributed to different studied ethnic population, different geographic areas, different sample size and genotyping methods used. Recently Tian, et al [18] presented metaanalysis with the largest dataset to date that did not show a statistically significant association of p53 codon 72 polymorphism and the overall BCC risk. Even subgroup analysis by ethnicity with different genetic models did not show any significant association in Caucasians as well as in Asians population.
[8] The association of the p53 codon 72 polymorphism and skin cancer in general was also explored in different metaanalysis studies 19,20 and indicated that p53 codon 72 polymorphism may have a little association with skin cancer. The low frequency p53 Arginine allele in the present study (10.3% for cases and 6.5% for controls) could be explained by the fact that frequency of p53 codon 72 Arginine allele increases with geographic distance from the equator and that fair skin population have higher frequency of p53 Arg allele than dark skin population. [21, 22] Most of these studies were conducted on Caucasian population and only one involves Asian population in Iran 8 which included the BCC and revealed no significant difference in the p53 genotypes between patients and controls but indicated an increase in the frequency of arginine allele among sun exposed compared to control which may affect the risk of UV induced BCC. However, a positive association of the p53 codon 72 and BCC was found in transplant patient by McGregor, et al [1] but not in immunocompetent group.
In conclusion, the study suggested that p53 codon 72 Arginine / proline heterozygous tend to confer a genetic susceptability in BCC development. The negative expression of the HPV 5,8 E6 oncoprotein should be confirmed by larger sample size and more reliable real time PCR.
susceptibility to sunburn and skin cancer. J
